PlainRecalls
FDA Food Critical Class I Terminated

PHENTALENE (TM), PHARMACEUTICAL GRADE, With 50 mg of Ephedra Extract, 90 CAPSULES, Distributed by Beta Labs, LTD, Newark, DE 19711, UPC 670541599822

Reported: September 3, 2014 Initiated: June 20, 2013 #F-2399-2014

Product Description

PHENTALENE (TM), PHARMACEUTICAL GRADE, With 50 mg of Ephedra Extract, 90 CAPSULES, Distributed by Beta Labs, LTD, Newark, DE 19711, UPC 670541599822

Reason for Recall

The products contain DMAA, also known as 1,3-dimethylamylamine, methylhexamine or geranium extract, which is not permitted in dietary supplements.

Details

Recalling Firm
Beta Labs
Units Affected
2154 units
Distribution
nationwide and UK
Location
Memphis, TN

Frequently Asked Questions

What product was recalled?
PHENTALENE (TM), PHARMACEUTICAL GRADE, With 50 mg of Ephedra Extract, 90 CAPSULES, Distributed by Beta Labs, LTD, Newark, DE 19711, UPC 670541599822. Recalled by Beta Labs. Units affected: 2154 units.
Why was this product recalled?
The products contain DMAA, also known as 1,3-dimethylamylamine, methylhexamine or geranium extract, which is not permitted in dietary supplements.
Which agency issued this recall?
This recall was issued by the FDA Food on September 3, 2014. Severity: Critical. Recall number: F-2399-2014.